Australia's Elixinol falls as virus curbs dent Q3 revenue

Elixinol Wellness

15/10/2021 05:40

** Medicinal cannabis maker Elixinol Global  EXL.AX  falls
as much as 2.2% to A$0.088
    ** Co posts Q3 FY21 rev of A$2.2 mln ($1.63 mln), down from
A$4 mln in Q3 FY20, due to COVID-19 restrictions impacting Hemp
Foods Australia Pty, a unit of co  urn:newsml:reuters.com:*:nASXXkl2k
    ** Elixinol Americas revenue 11% lower va Q2 FY21, due to
supply chain disruptions
    ** ~858,000 shares change hands vs 30-day avg volume of
480,000 shares
    ** Stock on track to post second consecutive session of
losses and third weekly loss
    ** EXL down 48.6% this year, as of last close

($1 = 1.3479 Australian dollars)

 (Reporting by Aditya Munjuluru in Bengaluru)
 ((aditya.srivastsav@thomsonreuters.com))